
Nothing about Abbvie’s (ABBV) share volume indicates investors were either enthusiastic or pessimistic about its stock on Wednesday.
The maker of Humira, the company’s blockbuster rheumatoid arthritis drug, had a total volume yesterday of a little more than four million shares, one-third less than its 30-day average. It ended up less than 1% higher on the day.